PI
ADMA icon

PFG Investments’s ADMA Biologics ADMA Stock Holding History

PFG Investments’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.26M Buy
270,178
+47,449
+21% +$433K 0.09% 197
2026
Q1 		$2.01M Buy
222,729
+8,728
+4% +$138K 0.09% 193
2025
Q4 		$3.9M Sell
214,001
-7,514
-3% -$127K 0.18% 104
2025
Q3 		$3.25M Buy
221,515
+6,025
+3% +$103K 0.17% 113
2025
Q2 		$3.92M Sell
215,490
-7,319
-3% -$149K 0.23% 80
2025
Q1 		$4.42M Buy
222,809
+1,301
+0.6% +$22.5K 0.28% 73
2024
Q4 		$3.8M Buy
221,508
+355
+0.2% +$6.68K 0.24% 79
2024
Q3 		$4.42M Sell
221,153
-43,987
-17% -$684K 0.29% 67
2024
Q2 		$2.96M Sell
265,140
-69,460
-21% -$583K 0.21% 86
2024
Q1 		$2.21M Buy
334,600
+291,600
+678% +$1.59M 0.13% 171
2023
Q4 		$194K Sell
43,000
-13,000
-23% -$48.1K 0.04% 459
2023
Q3 		$200K Sell
56,000
-16,500
-23% -$63.5K 0.04% 462
2023
Q2 		$268K Sell
72,500
-15,000
-17% -$55.6K 0.05% 396
2023
Q1 		$290K Buy
+87,500
New +$302K 0.06% 346

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

PFG Investments's ADMA Position: Q2 2026 in Review

PFG Investments increased its ADMA Biologics (ADMA) stake by 21% in Q2 2026, buying an estimated $433K and bringing the position to 270,178 shares worth $2.26M. The position accounts for 0.09% of the portfolio, ranked #197.

PFG Investments first reported a position in ADMA in Q1 2023 and has held it in 14 quarters since. The position peaked at $4.42M in Q3 2024. 323 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • PFG Investments held 270,178 shares of ADMA Biologics worth $2.26M as of Q2 2026.
  • PFG Investments bought 47,449 ADMA Biologics shares in Q2 2026, an estimated $433K.
  • ADMA Biologics made up 0.09% of PFG Investments's portfolio in Q2 2026, its #197 holding.
  • PFG Investments first reported a position in ADMA Biologics in Q1 2023 and has held it in 14 quarters since.
  • PFG Investments's ADMA Biologics position peaked at $4.42M in Q3 2024.
  • 323 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on PFG Investments's 13F filing for Q2 2026, filed 23 Jul 2026.